DocuSign, Inc. (NASDAQ:DOCU - Get Free Report) CFO Blake Jeffrey Grayson sold 15,588 shares of the firm's stock in a transaction that occurred on Wednesday, December 18th. The shares were sold at an average price of $97.78, for a total transaction of $1,524,194.64. Following the completion of the transaction, the chief financial officer now owns 85,851 shares of the company's stock, valued at $8,394,510.78. This trade represents a 15.37 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Blake Jeffrey Grayson also recently made the following trade(s):

DOCU stock traded down $5.46 during trading on Wednesday, hitting $92.71. 5,850,144 shares of the company traded hands, compared to its average volume of 3,008,476. The company has a 50-day moving average of $79.37 and a 200-day moving average of $64.02. The firm has a market capitalization of $18.73 billion, a PE ratio of 19.12, a P/E/G ratio of 8.72 and a beta of 0.92. DocuSign, Inc. has a 1 year low of $48.70 and a 1 year high of $107.86.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC lifted its holdings in DocuSign by 55.3% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 8,213 shares of the company's stock worth $439,000 after buying an additional 2,925 shares during the period. Atria Wealth Solutions Inc. grew its holdings in shares of DocuSign by 20.7% during the 2nd quarter. Atria Wealth Solutions Inc. now owns 14,603 shares of the company's stock worth $781,000 after acquiring an additional 2,507 shares during the period. Oak Family Advisors LLC grew its stake in DocuSign by 51.5% in the second quarter. Oak Family Advisors LLC now owns 95,495 shares of the company's stock worth $5,109,000 after purchasing an additional 32,472 shares during the period. &PARTNERS bought a new position in DocuSign in the second quarter worth $403,000. Finally, AMG National Trust Bank bought a new stake in shares of DocuSign during the 2nd quarter valued at $1,247,000. 77.64% of the stock is currently owned by institutional investors.

DOCU has been the subject of several research analyst reports. HSBC reissued a "reduce" rating on shares of DocuSign in a research note on Friday, December 6th. Morgan Stanley upped their price objective on shares of DocuSign from $62.00 to $97.00 and gave the stock an "equal weight" rating in a research report on Friday, December 6th. Citigroup lifted their target price on shares of DocuSign from $87.00 to $113.00 and gave the company a "buy" rating in a research report on Friday, December 6th. JPMorgan Chase & Co. boosted their price target on shares of DocuSign from $50.00 to $70.00 and gave the stock an "underweight" rating in a research note on Tuesday, December 3rd. Finally, Jefferies Financial Group raised their price objective on shares of DocuSign from $80.00 to $95.00 and gave the company a "buy" rating in a research report on Tuesday, December 3rd. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat, DocuSign currently has an average rating of "Hold" and an average price target of $92.45.

View Our Latest Stock Report on DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider DocuSign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.

While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.